Ischemic stroke
Conditions
Interventions
experience group:Routine ischemic stroke treatment, and give Angong Niuhuang Pill 3G / time, nasal feeding or oral, once a day for 7 days
Sponsors
The first people's Hospital of Yuhang District, Hangzhou City, Zhejiang Province
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Over 18 years old; (2) Acute severe ischemic stroke (NIHSS score > 15); (3) Within 24 hours of onset; (4) The diagnosis of cerebral infarction was in line with the standards of Chinese guidelines for the diagnosis and treatment of acute ischemic stroke 2018; (5) The patient or the patient's agent signs the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with acute cerebral infarction receiving thrombolysis or surgery; (2) Patients with end-stage status at admission (GCS score < 5 or mydriasis fixed); (3) History of intracranial hemorrhage, intracranial space occupying, brain trauma or other brain diseases; (4) Patients with severe liver insufficiency (CTP grade B or above) and severe renal insufficiency (CCR < 30ml / min); (5) Patients with primary diseases and malignant tumors of hematopoietic system and immune system; (6) Patients who refused or withdrew from the study due to various reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 28 day mortality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood arsenic concentration;Urinary mercury concentration;Urinary arsenic concentration;Blood mercury concentration;Improvement rate of early consciousness; | — |
Countries
China
Contacts
Public ContactYunlong Wu
The first people's Hospital of Yuhang District, Hangzhou City, Zhejiang Province
Outcome results
None listed